• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Global Endometrial Cancer Therapeutics Market to Reach $27 Billion by 2021 - Obesity Fuelling Endometrial Cancer Incidences - Research and Markets

    Global Endometrial Cancer Therapeutics Market to Reach $27 Billion by 2021 - Obesity Fuelling Endometrial Cancer Incidences - Research and Markets

  2. World Lung Cancer Therapeutics Market Opportunities and Forecasts 2014-2017 & 2022: Leading Companies are Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Co, Pfizer, and Agennix - Research ...

    World Lung Cancer Therapeutics Market Opportunities and Forecasts 2014-2017 & 2022: Leading Companies are Roche, Merck, AstraZeneca, Sanofi-Aventis, Eli Lilly and Co, Pfizer, and Agennix - Research and Markets

  3. Futurpreneur Canada™-Supported Entrepreneur Receives Prestigious Innovation Award

    Futurpreneur Canadaâ„¢-Supported Entrepreneur Receives Prestigious Innovation Award

  4. ImmunoGen Reports Recent Progress and First Quarter 2017 Operating Results

    ImmunoGen Reports Recent Progress and First Quarter 2017 Operating Results

  5. Global Non-small Cell Lung Cancer (NSCLC) Therapeutics Market 2014-2025 By Drug (Alimta, Iressa, Avastin, Tarceva, Zykadia, Tagrisso, Xalkori, Cyramza, Opdivo, Alecensa) And Segment Forecasts - ...

    Global Non-small Cell Lung Cancer (NSCLC) Therapeutics Market 2014-2025 By Drug (Alimta, Iressa, Avastin, Tarceva, Zykadia, Tagrisso, Xalkori, Cyramza, Opdivo, Alecensa) And Segment Forecasts - Research and Markets

©2017 Morningstar Advisor. All right reserved.